Log In
person
Vifor Pharma AG
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2020
| Reporting Segmentarrow_drop_up | Product Line | Amount (CHF) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (CHF) | Percentage |
| Net Sales |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
1.71B | 94.65% |
| Other Income |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
0.1B | 5.35% |
| keyboard_arrow_down |
Net Sales
Branded Pharmaceuticals
|
1.71B | 94.65% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Other Income
Pharmaceutical Patent Licensing
|
0.1B | 5.35% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||